CinCor Pharma to Present at Upcoming Piper Sandler and Evercore ISI Investor Conferences
CinCor Pharma announced participation in two investor conferences in late November 2022.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
CinCor Pharma announced participation in two investor conferences in late November 2022. The first is the Piper Sandler 34th Annual Healthcare Conference, held from November 29 to December 1, with a presentation on November 29 at 1:30 PM EST in New York. The second is the Evercore ISI 5th Annual HealthCONx Conference, taking place virtually from November 30 to December 1, featuring a presentation on December 1 at 3:30 PM EST. Archived replays will be available on their website.
Details
News Market Reaction – CINC
The recorded move for CINC in the trading session of this news was +3.10%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
WALTHAM, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (NASDAQ: CINC) today announced that company management will present at the following investor conferences in November:
| Event: | Piper Sandler 34th Annual Healthcare Conference |
| Date: | November 29 – December 1, 2022 |
| Location: | Lotte New York Palace in New York, New York |
| Presentation: | Tuesday, November 29, 2022 at 1:30pm EST |
| Webcast: | https://event.webcasts.com/starthere.jsp?ei=1585686&tp_key=3261cabcd6 |
| Event: | Evercore ISI 5th Annual HealthCONx Conference |
| Date: | November 30 – December 1, 2022 |
| Location: | Virtual |
| Presentation: | Thursday, December 1, 2022 at 3:30pm EST |
| Webcast: | https://wsw.com/webcast/evercore29/cinc/2336910 |
The CinCor management team will participate in one-on-one investor meetings during these events. Investors interested in meeting with CinCor at the conference should contact their Piper Sandler or Evercore ISI representative. An archived replay of the presentations will be available for 90 days at CinCor.com/events.
About CinCor
CinCor, founded in 2018, is a clinical-stage biopharmaceutical company with a mission to bring innovation to the pharmaceutical treatment of cardio-renal diseases. Its lead asset, baxdrostat, a highly selective, oral small molecule inhibitor of aldosterone synthase, is in clinical development for the treatment of hypertension and primary aldosteronism.
| Contacts: | Investors: |
| Michael Kalb | Bob Yedid |
| CinCor Pharma, Inc. | LifeSci Advisors |
| EVP and CFO | ir@CinCor.com |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.